最新报道:Injective (INJ) surged 15% following the launch of its Ethereum Virtual Machine (EVM) testnet, signaling a potential trend reversal. The Layer-1 blockchain's EVM compatibility aims to attract Ethereum developers, enhancing interoperability and expanding its ecosystem. Analysts note bullish technical indicators, including a breakout above key resistance levels, suggesting renewed investor confidence. The testnet launch aligns with Injective's broader strategy to integrate decentralized finance (DeFi) and Web3 applications, positioning it competitively amid growing Layer-1 adoption. Market observers highlight INJ's strong performance relative to major altcoins, with trading volume doubling amid the rally.